Literature DB >> 27698446

Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.

T Harada1, H Miki2, Q Cui1, A Oda1, R Amachi3, J Teramachi4, A Bat-Erdene1, K Sogabe1, M Iwasa1, S Fujii1, S Nakamura1, K Kagawa1, S Yoshida1, I Endo1, K Aihara1, S Ozaki5, T Matsumoto6, M Abe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27698446     DOI： 10.1038/leu.2016.273

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  Immunoregulation in the tissues by gammadelta T cells.

Authors:  Adrian Hayday; Robert Tigelaar
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

Review 2.  Cereblon binding molecules in multiple myeloma.

Authors:  K M Kortüm; Y X Zhu; C X Shi; P Jedlowski; A K Stewart
Journal:  Blood Rev       Date:  2015-03-27       Impact factor: 8.250

Review 3.  Understanding the complexity of γδ T-cell subsets in mouse and human.

Authors:  Dick J Pang; Joana F Neves; Nital Sumaria; Daniel J Pennington
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

4.  Professional antigen-presentation function by human gammadelta T Cells.

Authors:  Marlène Brandes; Katharina Willimann; Bernhard Moser
Journal:  Science       Date:  2005-06-02       Impact factor: 47.728

5.  Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.

Authors:  Qu Cui; Hironobu Shibata; Asuka Oda; Hiroe Amou; Ayako Nakano; Kenichiro Yata; Masahiro Hiasa; Keiichiro Watanabe; Shingen Nakamura; Hirokazu Miki; Takeshi Harada; Shiro Fujii; Kumiko Kagawa; Kyoko Takeuchi; Shuji Ozaki; Toshio Matsumoto; Masahiro Abe
Journal:  Int J Hematol       Date:  2011-06-23       Impact factor: 2.490

6.  Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.

Authors:  S Mariani; M Muraro; F Pantaleoni; F Fiore; B Nuschak; S Peola; M Foglietta; A Palumbo; M Coscia; B Castella; B Bruno; R Bertieri; L Boano; M Boccadoro; M Massaia
Journal:  Leukemia       Date:  2005-04       Impact factor: 11.528

Review 7.  Six-of-the-best: unique contributions of γδ T cells to immunology.

Authors:  Pierre Vantourout; Adrian Hayday
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

8.  Gammadelta T cells and the lymphoid stress-surveillance response.

Authors:  Adrian C Hayday
Journal:  Immunity       Date:  2009-08-21       Impact factor: 31.745

9.  Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds.

Authors:  Kathryn Lagrue; Alex Carisey; David J Morgan; Rajesh Chopra; Daniel M Davis
Journal:  Blood       Date:  2015-05-22       Impact factor: 22.113

10.  Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.

Authors:  Barbara Castella; Myriam Foglietta; Patrizia Sciancalepore; Micol Rigoni; Marta Coscia; Valentina Griggio; Candida Vitale; Riccardo Ferracini; Elona Saraci; Paola Omedé; Chiara Riganti; Antonio Palumbo; Mario Boccadoro; Massimo Massaia
Journal:  Oncoimmunology       Date:  2015-05-26       Impact factor: 8.110
View more
  1 in total

1.  Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells.

Authors:  Emanuela Chiarella; Bruna Codispoti; Annamaria Aloisio; Emanuela G Cosentino; Stefania Scicchitano; Ylenia Montalcini; Daniela Lico; Giovanni Morrone; Maria Mesuraca; Heather M Bond
Journal:  Heliyon       Date:  2020-06-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.